Article Details
Retrieved on: 2019-05-31 00:53:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors decreased Aerie Pharmaceuticals Com (AERI) stake by 25.37% reported in 2018Q4 SEC filing. <b>Benchmark Capital</b> ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here